Fecal Microbiota Transplant for Improvement of Metabolism

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Obesity

In brief

The purpose of this study is to study the impact of gut bacteria on weight. Fecal microbiota transplantation (FMT) transfers intestinal bacteria by a "stool transplant" from a healthy, lean person to a person with obesity.

Key facts

Study ID

NCT02530385

Run by

Massachusetts General Hospital

People needed

24

Starts

2016-06-01

Expected to finish

2018-06-27

Last updated by the study team

2019-07-25

Who can join

Age: 25 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BMI ≥30 kg/m2
• Because of frequent study mandated visits, only subjects living within reasonable driving distance of Massachusetts General Hospital may be enrolled

You may not qualify if…

• Pregnant women
• Use of diabetic medications or weight loss medications in the preceding 1 year
• Significant gastrointestinal disorders
• Significant food allergies
• Immunosuppressed patients

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.